Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
tags : Biotech-beach symbols : Jnj save search
Capstan Secures $175M Oversubscribed Series B with Backing from J&J, Bayer and BMS
Published: 2024-03-21 (Crawled : 15:30) - biospace.com/
JNJ | News | $145.74 0.67% -0.18% 7M
|
Health Technology
|
| O: -0.03%
H: 0.0%
C: 0.0%
series
Biosense Webster Announces Regulatory Approval of VARIPULSE™ Pulsed Field Ablation (PFA) Platform in Japan
Published: 2024-01-09 (Crawled : 20:00) - biospace.com/
JNJ | News | $145.74 0.67% -0.18% 7M
|
Health Technology
|
| O: 0.23%
H: 0.0%
C: 0.0%
japan approval platform
Pipeline Therapeutics Changes Name to Contineum Therapeutics to Reflect Expanded Focus on NI&I Therapeutic Indications (Neuroscience, Inflammation and Immunology)
Published: 2023-12-13 (Crawled : 17:00) - biospace.com/
JNJ | News | $145.74 0.67% -0.18% 7M
|
Health Technology
|
| O: -0.71%
H: 0.0%
C: 0.0%
pipeline therapeutics
DARZALEX FASPRO® (daratumumab and hyaluronidase-fihj)-based quadruplet therapy regimen shows significant improvement in outcomes for patients with transplant-eligible newly diagnosed multiple myeloma
Published: 2023-12-12 (Crawled : 21:00) - biospace.com/
GNMSF | $290.38 3.33% 3.83% 220
|
Health Technology
|
| O: -4.43%
H: 0.76%
C: -0.99%
JNJ | News | $145.74 0.67% -0.18% 7M
|
Health Technology
|
| O: 0.1%
H: 0.0%
C: 0.0%
GMAB | $28.33 -0.7% -0.74% 220K
|
Health Technology
|
| O: -5.33%
H: 0.46%
C: 0.13%
faspro darzalex therapy
Arialys Therapeutics Launches to Lead the Development of New Precision Medicines for Autoimmune Neuropsychiatric Diseases
Published: 2023-09-12 (Crawled : 12:00) - biospace.com/
JNJ | News | $145.74 0.67% -0.18% 7M
|
Health Technology
|
| O: 0.62%
H: 0.0%
C: 0.0%
neuropsychiatric therapeutics
Rapport Therapeutics Raises $150 Million in Series B Funding Round and Announces Key Board Appointments to Further Advance Precision Neuromedicine Platform
Published: 2023-08-23 (Crawled : 10:37) - biospace.com/
JNJ | News | $145.74 0.67% -0.18% 7M
|
Health Technology
|
| O: -0.25%
H: 0.0%
C: 0.0%
therapeutics funding platform
Biosense Webster Launches the OPTRELL™ Mapping Catheter with TRUEref™ Technology for Mapping of Complex Cardiac Arrhythmias
Published: 2023-07-24 (Crawled : 18:00) - biospace.com/
JNJ | News | $145.74 0.67% -0.18% 7M
|
Health Technology
|
| O: 0.77%
H: 1.35%
C: -0.24%
cardiac technology
Appia Bio Expands Leadership Team With Sylvaine Cases, Ph.D. Appointed Chief Business Officer and Alex Babayan, Ph.D. as Vice President, Head of Regulatory Affairs
Published: 2023-06-28 (Crawled : 14:00) - biospace.com/
JNJ | News | $145.74 0.67% -0.18% 7M
|
Health Technology
|
| O: -0.06%
H: 0.0%
C: -0.15%
SNY | News | $45.39 -1.56% -1.58% 4.3M
|
Health Technology
|
| O: 0.75%
H: 0.0%
C: 0.0%
business
New Data Published on Biosense Webster QDOT MICRO™ Catheter - the Latest Advancement in Focal RF Ablation for Treating AFib
Published: 2023-05-15 (Crawled : 16:00) - biospace.com/
JNJ | News | $145.74 0.67% -0.18% 7M
|
Health Technology
|
| O: 0.01%
H: 0.14%
C: -0.78%
Nexcella Announces 2023 Haematologica Editorial Highlighting NXC-201 Efficacy In The Context of U.S. Food And Drug Administration Approved BCMA CAR T Cells
Published: 2023-03-31 (Crawled : 18:00) - biospace.com/
IMMX | News | $2.21 -11.6% -11.11% 190K
|
|
| O: 2.33%
H: 6.24%
C: 3.41%
JNJ | News | $145.74 0.67% -0.18% 7M
|
Health Technology
|
| O: 0.23%
H: 0.91%
C: 0.79%
nxc-201 drug approved food
STAAR Surgical Names Warren Foust Chief Operating Officer; Magda Michna, Ph.D., Chief Clinical, Regulatory and Medical Affairs Officer
Published: 2023-03-29 (Crawled : 12:00) - biospace.com/
JNJ | News | $145.74 0.67% -0.18% 7M
|
Health Technology
|
| O: 0.28%
H: 0.75%
C: 0.7%
STAA | $46.77 0.93% 0.96% 380K
|
Health Technology
|
| O: 1.38%
H: 0.0%
C: -1.47%
medical
Cidara Therapeutics Provides Corporate Update and Reports Fourth Quarter and Full Year 2022 Financial Results
Published: 2023-03-23 (Crawled : 13:00) - biospace.com/
JNJ | News | $145.74 0.67% -0.18% 7M
|
Health Technology
|
| O: 0.08%
H: 0.34%
C: -0.03%
CDTX | $0.722 -0.03% -0.29% 270K
|
Health Technology
|
| O: -10.53%
H: 1.18%
C: -15.88%
year update therapeutics financial results
STAND UP TO CANCER ANNOUNCES FOUR TEAMS FOCUSED ON DIVERSITY IN EARLY PHASE CANCER CLINICAL TRIALS
Published: 2023-02-08 (Crawled : 15:20) - biospace.com/
JNJ | News | $145.74 0.67% -0.18% 7M
|
Health Technology
|
| O: -0.06%
H: 0.77%
C: 0.19%
trials cancer
Rancho Biosciences Welcomes BenevolentAI as New Member to Its Single Cell Data Science Consortium
Published: 2023-02-01 (Crawled : 16:00) - biospace.com/
JNJ | News | $145.74 0.67% -0.18% 7M
|
Health Technology
|
| O: -0.26%
H: 1.83%
C: 1.18%
Dexcom Appoints Teri Lawver as Chief Commercial Officer
Published: 2023-01-09 (Crawled : 14:00) - biospace.com/
JNJ | News | $145.74 0.67% -0.18% 7M
|
Health Technology
|
| O: -0.53%
H: 0.26%
C: -2.07%
DXCM | $134.3 0.33% 0.33% 1.5M
|
Health Technology
|
| O: -2.9%
H: 1.09%
C: -2.13%
commercial
Arcturus Therapeutics to Report Third Quarter 2022 Financial Results and Provide Corporate Update on November 9, 2022
Published: 2022-10-26 (Crawled : 22:00) - biospace.com/
JNJ | News | $145.74 0.67% -0.18% 7M
|
Health Technology
|
| O: 0.5%
H: 0.0%
C: 0.0%
ARCT 4 | $26.32 -4.78% -5.06% 610K
|
Health Technology
|
| O: -0.12%
H: 8.05%
C: 2.28%
report therapeutics financial update results
Arcturus Reports Durability Data Against Omicron Variants, Including BA.5, at Six-Month Timepoint Following Booster with ARCT-154 COVID-19 Vaccine
Published: 2022-08-18 (Crawled : 13:00) - biospace.com/
JNJ | News | $145.74 0.67% -0.18% 7M
|
Health Technology
|
| O: 0.85%
H: 0.0%
C: 0.0%
ARCT 4 | $26.32 -4.78% -5.06% 610K
|
Health Technology
|
| O: 0.0%
H: 0.26%
C: -8.59%
arct-154 covid-19 vaccine
Arcturus Therapeutics to Report Second Quarter 2022 Financial Results and Provide Corporate Update on August 9, 2022
Published: 2022-08-01 (Crawled : 21:00) - biospace.com/
JNJ | News | $145.74 0.67% -0.18% 7M
|
Health Technology
|
| O: 0.22%
H: 0.0%
C: 0.0%
ARCT 4 | $26.32 -4.78% -5.06% 610K
|
Health Technology
|
| O: -2.17%
H: 7.16%
C: 1.75%
report therapeutics update results
Innovative Platform for Tracking High-Value Medical DevicesTruepic to Work with “DePuy Synthes Canada*” to Increase Efficiency and Reduce Risk
Published: 2022-08-01 (Crawled : 17:00) - biospace.com/
JNJ | News | $145.74 0.67% -0.18% 7M
|
Health Technology
|
| O: 0.22%
H: 0.0%
C: 0.0%
risk work platform
BioTools Innovator Announces Top 14 Life Sciences Companies Selected for 2022 Cohort
Published: 2022-07-06 (Crawled : 12:00) - biospace.com/
JNJ | News | $145.74 0.67% -0.18% 7M
|
Health Technology
|
| O: -0.48%
H: 0.0%
C: 0.0%
sciences companies life
Gainers vs Losers
| 59% | 41% |
Top 10 Gainers
AGBA | News | $1.03 157.5% 57.94% 120M
|
Finance
ZCMD | $1.45 5.84% 52.1% 2.3M
|
Commercial Services
INVO | $1.52 100.0% 51.13% 5M
|
Health Technology
ISPC | $0.421 97.65% 49.53% 37M
|
Professional, Scientific, and T...
WLGS | News | $0.5 45.65% 470K
|
OST | $0.509 23.81% 45.26% 90K
|
GDHG | $0.263 21.76% 40.66% 3.1M
|
XPON | News | $3.15 63.21% 37.74% 16M
|
TIRX | $0.8 65.02% 30.74% 58M
|
BNTC | News | $6.82 42.08% 30.64% 3.5M
|
Health Technology
Your saved searches
Save your searches and get alerts when important news are released.